Longer duration of dual antiplatelet therapy after stent placement improves outcomes for patients with peripheral arterial disease

August 30, 2016

In a study published online by JAMA Cardiology, Marco Valgimigli, M.D., Ph.D., of Bern University Hospital, Bern, Switzerland, and colleagues assessed the efficacy and safety of prolonged (24 months) vs short (6 months or less) dual antiplatelet therapy in patients with peripheral arterial disease undergoing percutaneous coronary intervention. The study is being released to coincide with its presentation at the European Society of Cardiology Congress 2016.

Concomitant (accompanying) peripheral arterial disease (PAD) is increasingly recognized as an important risk factor among patients with coronary artery disease. Evidence suggests that extended duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI; a procedure used to open narrowed coronary arteries, such as stent placement) provides more effective protection against atherothrombotic events (formation of a blood clot) compared with short-term regimens, at the risk of more frequent bleeding.

This study, which assessed patients from tertiary care hospitals with stable coronary artery disease or acute coronary syndromes with or without concomitant PAD, was a subanalysis of the PRODIGY trial, which compared the safety and efficacy profile of prolonged vs short duration of DAPT in a population of patients undergoing coronary stenting.

The analysis included 246 and 1,724 patients with and without PAD, respectively. The authors write that the primary findings were that in patients undergoing PCI, concomitant PAD was associated with a 2-fold increased risk of ischemic events, whereas the risk of bleeding was unaffected; and prolonged DAPT duration of 24 months after PCI reduced the risk of death, heart attack, or cerebrovascular accident (stroke) compared with short DAPT of 6 months or less in patients with PAD. The improved efficacy of prolonged DAPT in patients with PAD was not offset by an increased risk of actionable (requiring clinical action) bleeding episodes. The researchers note that this finding requires further evaluation in adequately powered studies.
-end-
(JAMA Cardiology. Published online Aug. 30, 2016; doi:10.1001/jamacardio.2016.2811. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: Available pre-embargo at the For The Media website is an accompanying commentary, "Antithrombotic Therapy in Patients With Peripheral Artery Disease" by Marc P. Bonaca, M.D., M.P.H., of the TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston.

The JAMA Network Journals

Related Coronary Artery Disease Articles from Brightsurf:

Researchers use multi-ancestry comparison to refine risk factors for coronary artery disease
An international group led by researchers from the RIKEN Center for Integrative Medical Sciences have used a combination of genome-wide association analysis--or GWAS--and a trans-ancestry comparison of different GWAS studies, to come up with a more accurate predictor of coronary artery disease based on genetic factors.

Oral radiography can reveal chronic coronary artery disease
A study found a link between carotid artery calcification observable in radiographs and coronary artery disease as well as several oral infections.

A new strategy to counter insulin damage in coronary artery disease
By studying blood vessel tissue from 674 patients, a research team has discovered how insulin contributes to the dysfunction of blood vessels in atherosclerosis, one of the most common chronic health conditions worldwide.

3D fusion imaging improves coronary artery disease diagnosis
A new technique that combines CT and MRI can bolster coronary artery disease diagnosis and help to define appropriate treatment for patients suffering from the disease, according to a new study.

Associations between vaspin levels and coronary artery disease
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0565, Lutfu Askin, Okan Tanriverdi, Hakan Tibilli and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider associations between vaspin levels and coronary artery disease.

Waist size, not body mass index, may be more predictive of coronary artery disease
For years, women have been told that weight gain could lead to heart disease.

Women with coronary artery wall thickness at risk for heart disease
The thickness of the coronary artery wall as measured by MRI is an independent marker for heart disease in women, according to a new study.

SPIE journal reports advances in use of 3D models in assessing coronary artery disease
In an article published in SPIE's Journal of Medical Imaging (JMI), researchers announce critical advances in the use of 3D-printed coronary phantoms with diagnostic software, further developing a non-invasive diagnostic method for Coronary Artery Disease (CAD) risk assessment.

E-cigarettes linked to heart attacks, coronary artery disease and depression
Concerns about the addictive nature of e-cigarettes -- now used by an estimated 1 out of 20 Americans -- may only be part of the evolving public health story surrounding their use, according to data being presented at the American College of Cardiology's 68th Annual Scientific Session.

Is guideline-recommended therapy for coronary artery disease more likely in Medicare Advantage?
Medicare Advantage is Medicare's managed-care alternative to traditional fee-for-service Medicare.

Read More: Coronary Artery Disease News and Coronary Artery Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.